<?xml version="1.0" encoding="UTF-8"?>
<p>To overcome these issues, the researchers are ardently seeking alternative bioactive molecules (antimicrobial, antioxidant, and anticancer), with high efficacy and fewer secondary effects. Lichen secondary metabolites have been documented widely for their effectiveness against different tumor cells and also for their bacterial resistance potential. As far as we can tell, a few studies have evaluated the anticancer activity of 
 <italic>Evernia prunastri, Pseudevernia furfuracea</italic>, and 
 <italic>Ramalina farinacea.</italic> However, the Moroccan lichens have not yet been studied in terms of pharmacological effects.
</p>
